跳至主要内容
临床试验/NCT06654115
NCT06654115进行中(未招募)不适用

Wireless Vital Sign Monitoring in Women After Cesarean Birth in Pakistan

Lund University2 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2023年10月22日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
100
试验地点
2
主要终点
Clinical Adequacy Score

研究概览

简要总结

With over 18.5 million procedures performed worldwide and increasing, Cesarean section (CS) is the commonest surgical procedure. Inpatient monitoring is typically intense due to high risk for hemorrhage and other complications in the immediate post-operative period. Vital signs, including heart rate, blood pressure, saturation and temperature are monitored every 10-15 minutes. Maintaining this level of monitoring requires a significant dedication of human resources which is unattainable in resource-limited settings (RLS). Advancements in wireless physiologic monitoring offer a novel strategy to improve current monitoring levels. Through our project, we will evaluate the clinical use of a wireless physiological monitoring system for immediate postpartum monitoring in women after CS.

Our primary aims are:

I) To explore the clinical adequacy of wireless physiologic monitoring vs standard of care (SOC) monitoring immediately after uncomplicated Cesarean section in a RLS II) To explore the usability of wireless physiologic monitoring vs SOC monitoring among healthcare staff in a RLS

详细描述

Basic study design:

This pilot study will take place at Sir Ganga Ram Hospital, Lahore Pakistan as a cluster randomized clinical trial. Pakistan is a developing country with limited resources and a high maternal mortality rate of 189/100,000 live births. The tertiary hospital is located in the heart of historic city of Lahore which has a population of 11 million and the hospital has approximately 24,000 births per year. A conservative estimate of approximately 30 CS occur each day at the hospital.

Intervention:

Units will be randomized to the intervention, use of wireless physiologic monitoring system (WIP), or to SOC. The WIP system will be provided by YHE® BP Doctor Pro Blood Pressure Smartwatch, which is a commericially available device. The device can monitor heart rate

Randomization:

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Single Group
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • age ≥18 years, 2) undergoing CS for singleton pregnancy, 3) willing to stay in postpartum unit for at least 24 hours, 4) willing to wear sensor during their time at the post-operative monitoring ward, 5) able to provide consent 6) ability to speak Urdu/Punjabi or English

排除标准

  • women with complicated CS (e.g. due to excessive perioperative bleeding), 2) women with immediate-emergency CS due to fetal or maternal disease, 3) no informed, written consent 4) unwilling to wear devices or participate in questionnaires, or 5) known infectious disease including but not limited to viral hepatitis, tuberculosis, or HIV.

结局指标

主要结局

Clinical Adequacy Score

时间窗: 4 months

Composite adequacy score (CAS), is a composite of registered measurements of HR, saturation and BP measured during the first 2 hours after birth. Each registered vital sign will give 1 point.

次要结局

  • System Usuability Scale index(4 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验